Monoclonal Antibodies Market

The monoclonal antibodies (mAbs) market encompasses the development, production, and sale of laboratory-produced antibodies for therapeutic applications. Key customers are healthcare providers, primarily hospitals and specialty centers, which administer these treatments. The market's growth is driven by rising cancer incidences, increasing government initiatives for infection control, the high demand for biologics, and the need for cost-effective biosimilar alternatives.